https://ceqursimplicity7day.com/cequr-raises-115-million-series-c5/ 2021-12-28T20:09:33+00:00 https://ceqursimplicity7day.com/the-wider-view-with-new-ceo-in-place-cequr-primed-to-paq-a-punch-in-diabetes-market/ 2021-12-29T19:59:18+00:00 https://ceqursimplicity7day.com/two-new-wearable-pen-insulin-devices-coming-soon/ 2021-12-29T20:01:18+00:00 https://ceqursimplicity7day.com/high-treatment-satisfaction-with-3-day-insulin-patch-is-independent-of-patient-demographics-a-post-hoc-analysis-a-presentation-at-the-american-diabetes-association-80th-scientific-sessi/ 2021-12-30T01:53:26+00:00 https://ceqursimplicity7day.com/cequr-appoints-rick-doubleday-and-dr-meret-gaugler-to-board-of-directors/ 2023-02-27T01:43:52+00:00 https://ceqursimplicity7day.com/cequr-appoints-bradley-paddock-chief-executive-officer/ 2023-02-27T01:47:22+00:00 https://ceqursimplicity7day.com/wp-content/uploads/Bradley-Paddock-headshot.jpg https://ceqursimplicity7day.com/cequr-appoints-peter-b-luther-to-board-of-directors/ 2023-02-27T01:47:46+00:00 https://ceqursimplicity7day.com/wp-content/uploads/news-portrait-Peter-Luther_edited.png https://ceqursimplicity7day.com/cequr-acquires-assets-from-calibra-medical-inc/ 2023-02-27T01:48:16+00:00 https://ceqursimplicity7day.com/cequr-simplicity-4-day-wear/ 2024-06-18T13:56:22+00:00 https://ceqursimplicity7day.com/cequr-closes-a-120m-equity-financing-to-drive-commercial-growth/ 2025-01-07T06:00:42+00:00 https://ceqursimplicity7day.com/cequr-marks-10-million-mealtime-injections-replaced-and-highlights-commercial-expansion/ 2025-06-18T06:00:31+00:00 https://ceqursimplicity7day.com/cequr-announces-exciting-advancements-2-recent-fda-clearances-and-new-clinical-evidence-to-be-presented-at-ada/ 2026-06-04T10:57:11+00:00 https://ceqursimplicity7day.com/cequr-closes-100-million-series-e/ 2026-06-09T11:32:03+00:00